QLQ-C30 | Radiotherapy | p-value (no radio-therapy vs. neoadjuvant) | |
---|---|---|---|
no | neo-adjuvant | ||
(n = 31) 42% | (n = 39) 52% | ||
Global QoL score | 73.1 (65–81) | 58.6 (51–66) | 0.006* |
Physical function score | 88.1 (83–94) | 68.2 (60–76) | < 0.001* |
Role function score | 75.2 (67–84) | 52.9 (43–63) | 0.002* |
Emotional function score | 80.1 (73–87) | 65.3 (57–74) | 0.022* |
Cognitive function score | 88.8 (83–95) | 80.1 (72–88) | 0.247 |
Social function score | 87.6 (80–95) | 60,9 (51–71) | < 0.001* |
Fatigue score | 25.9 (15–37) | 43.4 (34–53) | 0.023* |
Pain score | 22 (13–31) | 42.9 (31–55) | 0.016* |
Insomnia score | 19.3 (10–29) | 25,4 (15–36) | 0.505 |
Appetite loss score | 3.2 (−0.4–6.9) | 3.9 (0.47–7.2) | 0.68 |
Nausea and vomiting score | 1.6 (−0–3.5) | 1.7 (− 0.3–3.8) | 0.824 |
Constipation score | 6.4 (−1.5–14) | 12.2 (4–21) | 0.151 |
Diarrhoea score | 6.4 (0.6–12) | 10.8 (4.3–17) | 0.286 |
Dyspnea score | 7.5 (2.3–13) | 22.8 (13–33) | 0.034* |
Financial problems score | 11.8 (2–22) | 31.5 (20–44) | 0.009* |